|
Male gender (%)
|
104(70.7)
|
78(68.4)
|
0.685
|
|
Age (yrs)
|
67±6
|
69±7
|
0.01
|
|
Chronic obstructive pulmonary disease (%)
|
98(66.7)
|
81(71.1)
|
0.449
|
|
Cardiogenic pulmonary edema (%)
|
13(8.8)
|
17(14.9)
|
0.127
|
|
Pneumonia (%)
|
40(27.2)
|
46(40.4)
|
0.025
|
|
Hypertension (%)
|
49(33.3)
|
40(35.1)
|
0.243
|
|
Systolic blood pressure (mmHg)
|
131±9
|
132±9
|
0.374`
|
|
Diastolic blood pressure (mmHg)
|
75±8
|
76±8
|
0.317
|
|
Red blood cell (x1012/L)
|
4.75±0.73
|
4.91±0.77
|
0.088
|
|
Hemoglobin (g/L)
|
132±12
|
134±13
|
0.199
|
|
Body temperature (°C)
|
37.3±0.1
|
37.4 ± 0.1
|
<0.001
|
|
Total cholesterol (mmo1/L)
|
4.06±0.91
|
4.17±0.95
|
0.343
|
|
HDL-cholesterol (mmo1/L)
|
1.19±0.26
|
1.17±0.27
|
0.545
|
|
LDL-cholesterol (mmo1/L)
|
2.43±0.62
|
2.41±0.68
|
0.805
|
|
Triglycerides (mmo1/L)
|
1.72±0.75
|
1.91± 0.78
|
0.047
|
|
Fasting Glucose (mmo1/L)
|
5.9±1.8
|
9.4±2.1
|
<0.001
|
|
2-h postprandial glucose (mmo1/L)
|
9.2±4.1
|
13.9± 4.5
|
<0.001
|
|
HbA1c (%)
|
5.6±1.2
|
9.2±2.1
|
<0.001
|
|
Blood urea nitrogen (mmo1/L)
|
5.42±2.35
|
6.03±2.51
|
0.045
|
|
Creatinine (μmo1/L)
|
87±16
|
91±18
|
0.59
|
|
Medical treatments
| | | |
|
ACEI or ARB (%)
|
46(31.3)
|
37(32.5)
|
0.841
|
|
Calcium channel blocker (%)
|
14(9.5)
|
12(10.5)
|
0.789
|
|
Statins* (%)
|
121(82.3)
|
97(85.1)
|
0.549
|
|
Metformin (%)
|
52(35.4)
|
45(39.5)
|
0.497
|
|
Sulphonylureas (%)
|
56(38.1)
|
37(32.5)
|
0.345
|
|
Alpha-glucosidase (%)
|
54(36.7)
|
46(40.3)
|
0.551
|
|
PPAR-gamma agonist (%)
|
23(15.6)
|
15(13.2)
|
0.572
|
